<p>Quantinno Capital Management LP 在最近向证券交易委员会提交的文件中表示，在第二季度将其在美敦力公司（NYSE:MDT - 免费报告）的股份增加了 42.1%。该基金在此期间购买了额外的 123,691 股后，持有该医疗技术公司 417,488 股股票。根据其最近向证券交易委员会提交的文件，Quantinno Capital Management LP 在美敦力的持股价值为 36,392,000 美元。</p>
<ul>
<li>美敦力股票找到支撑——现在正在获得动能</li>
</ul>
<p>其他机构投资者最近也买卖了该公司的股票。Brighton Jones LLC 在第四季度将其在美敦力的持股比例提高了 1,368.0%。Brighton Jones LLC 现在拥有 39,989 股美敦力的股票，价值 3,194,000 美元，此前在上个季度又收购了 37,265 股。Rathbones Group PLC 在第一季度将其在美敦力的股份增加了 43.6%。Rathbones Group PLC 现在拥有 8,131 股美敦力的股票，价值 731,000 美元，此前在上个季度又购买了 2,468 股。Vestmark Advisory Solutions Inc.在第一季度将其在美敦力的持股增加了 98.4%。Vestmark Advisory Solutions Inc.现在拥有 8,746 股美敦力的股票，价值 786,000 美元，此前在上个季度又购买了 4,338 股。Kovitz Investment Group Partners LLC 在第一季度将其在美敦力的持股提高了 43.8%。Kovitz Investment Group Partners LLC 现在拥有 108,030 股美敦力的股票，价值 9,708,000 美元，此前在上个季度又购买了 32,907 股。最后，Inspire Trust Co. N.A.在第一季度将其在美敦力的股份提高了 4.5%。Inspire Trust Co. N.A.现在拥有 46,000 股美敦力的股票，价值 4,134,000 美元，此前在上个季度又购买了 2,000 股。目前，82.06% 的股票由机构投资者和对冲基金持有。</p>
<h2>华尔街分析师观点</h2>
<p>几家研究公司最近对 MDT 发布了报告。摩根大通将美敦力的股票目标价从 90.00 美元上调至 100.00 美元，并在 11 月 13 日的研究报告中给予该股票 “中性” 评级。Sanford C. Bernstein 在 11 月 19 日的报告中设定了美敦力的目标价为 111.00 美元。富国银行在 11 月 19 日的研究报告中将美敦力的目标价从 100.00 美元上调至 114.00 美元，并给予该公司 “增持” 评级。Robert W. Baird 在 11 月 19 日的研究报告中将美敦力的目标价从 103.00 美元上调至 109.00 美元，并给予该股票 “中性” 评级。最后，瑞银集团在 11 月 19 日的研究报告中将美敦力的目标价从 95.00 美元上调至 102.00 美元，并给予该公司 “中性” 评级。一位分析师对该股票给予了强烈买入评级，十三位分析师给予买入评级，十二位分析师给予持有评级。根据 MarketBeat.com 的数据，该公司的平均评级为 “适度买入”，共识目标价为 110.44 美元。</p>
<ul>
<li>MarketBeat 周回顾 – 08/18 - 08/22</li>
</ul>
<p><strong>查看我们最新的美敦力股票报告</strong></p>
<h2>美敦力股价下跌 1.0%</h2>
<p>美敦力（NYSE:MDT）股票周五开盘价为 99.77 美元。该公司的流动比率为 2.42，速动比率为 1.80，债务与股本比率为 0.57。该股票的市值为 1279.1 亿美元，市盈率为 26.89，市盈增长比率为 2.65，贝塔值为 0.71。美敦力 PLC 的 12 个月低点为 79.29 美元，12 个月高点为 106.33 美元。该股票的 50 日简单移动平均线为 97.23 美元，200 日简单移动平均线为 92.66 美元。</p>
<ul>
<li>美敦力：收入投资者的机会变得更好</li>
</ul>
<p>美敦力（NYSE:MDT - 获取免费报告）最后一次公布财报是在 11 月 18 日，医疗技术公司报告季度每股收益为 1.36 美元，超出分析师一致预期的 1.31 美元，超出 0.05 美元。该公司在本季度的收入为 89.6 亿美元，而分析师预期为 88.6 亿美元。美敦力的股本回报率为 14.86%，净利润率为 13.71%。美敦力本季度的收入同比增长 6.6%。去年同期，该公司每股收益为 1.26 美元。美敦力已将其 2026 财年的指引设定为 5.620-5.660 每股收益。分析师平均预测美敦力 PLC 在当前年度的每股收益为 5.46 美元。</p>
<h2>美敦力分红公告</h2>
<p>该公司还最近宣布了一项季度分红，将于 1 月 16 日（星期五）支付。12 月 26 日（星期五）的登记投资者将获得每股 0.71 美元的分红。这相当于每年 2.84 美元的分红，收益率为 2.8%。该分红的除息日期为 12 月 26 日（星期五）。美敦力的分红支付比率目前为 76.55%。</p>
<h2>关于美敦力</h2>
<p>（免费报告）</p>
<p>美敦力公司开发、制造和销售基于设备的医疗疗法，服务于全球的医疗系统、医生、临床医生和患者。其心血管产品组合提供可植入的心脏起搏器、心脏复律除颤器和心脏再同步治疗设备；心脏消融产品；可植入心脏监测系统；TYRX 产品；以及远程监测和以患者为中心的软件。</p>
<h2>精选故事</h2>
<ul>
<li>五只我们更看好的股票超过美敦力</li>
<li>宝洁公司（NYSE: PG）在不稳定的指引后回落</li>
<li>分红强势股：3 只为长期投资而打造的蓝筹股</li>
<li>3 只可以提升您投资组合的家居改善股票</li>
<li>3 只最近被下调评级的股票，2026 年应避免</li>
<li>FAANG 股票是什么？它们是好的投资吗？</li>
<li>芯片热潮回归：3 只有望获得巨大收益的股票</li>
</ul>
<p><strong>想知道其他对冲基金持有 MDT 的情况吗？</strong> 请访问 HoldingsChannel.com 获取 Medtronic PLC (NYSE:MDT - 免费报告) 的最新 13F 文件和内部交易信息。</p>
<p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/SECFilingChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPU1EVA?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/SECFilingChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPU1EVA"/></p>
<p><em>此即时新闻提醒由叙事科学技术和 MarketBeat 的金融数据生成，旨在为读者提供最快的报道和公正的覆盖。请将任何问题或意见发送至 contact@marketbeat.com。</em></p>
<h2>你现在应该投资 1,000 美元在 Medtronic 吗？</h2>
<p>在考虑 Medtronic 之前，你需要听听这个。</p>
<p>MarketBeat 每天跟踪华尔街顶级评级和表现最佳的研究分析师及其推荐给客户的股票。MarketBeat 已识别出五只顶级分析师悄悄建议客户现在购买的股票，以便在更广泛的市场注意到之前……而 Medtronic 并不在名单上。</p>
<p>虽然 Medtronic 目前在分析师中有中等买入评级，但顶级分析师认为这五只股票更值得购买。</p>
<p>在这里查看这五只股票</p>

美敦力

<p>Quantinno Capital Management LP 在第二季度增持了美敦力（Medtronic PLC）42.1% 的股份，持有 417,488 股，价值 3639 万美元。分析师们发布了各种评级，普遍目标价为 110.44 美元。美敦力的股票开盘价为 99.77 美元，市值为 1279.1 亿美元。该公司报告第二季度每股收益为 1.36 美元，超出预期</p>

<p>Quantinno Capital Management LP increased its stake in shares of Medtronic PLC (NYSE:MDT - Free Report) by 42.1% in the 2nd quarter, according to the company in its most recent filing with the Securities &amp; Exchange Commission. The fund owned 417,488 shares of the medical technology company's stock after purchasing an additional 123,691 shares during the period. Quantinno Capital Management LP's holdings in Medtronic were worth $36,392,000 as of its most recent filing with the Securities &amp; Exchange Commission.</p>
<div class="lb-trans"><p>Quantinno Capital Management LP 在最近向证券交易委员会提交的文件中表示，在第二季度将其在美敦力公司（NYSE:MDT - 免费报告）的股份增加了 42.1%。该基金在此期间购买了额外的 123,691 股后，持有该医疗技术公司 417,488 股股票。根据其最近向证券交易委员会提交的文件，Quantinno Capital Management LP 在美敦力的持股价值为 36,392,000 美元。</p>
</div><ul>
<li>Medtronic Stock Finds Its Footing—Now It’s Gaining Momentum</li>
</ul>
<div class="lb-trans"><ul>
<li>美敦力股票找到支撑——现在正在获得动能</li>
</ul>
</div><p>Other institutional investors also recently bought and sold shares of the company. Brighton Jones LLC lifted its position in shares of Medtronic by 1,368.0% in the fourth quarter. Brighton Jones LLC now owns 39,989 shares of the medical technology company's stock valued at $3,194,000 after acquiring an additional 37,265 shares in the last quarter. Rathbones Group PLC boosted its stake in Medtronic by 43.6% during the 1st quarter. Rathbones Group PLC now owns 8,131 shares of the medical technology company's stock worth $731,000 after purchasing an additional 2,468 shares during the last quarter. Vestmark Advisory Solutions Inc. grew its holdings in shares of Medtronic by 98.4% during the first quarter. Vestmark Advisory Solutions Inc. now owns 8,746 shares of the medical technology company's stock worth $786,000 after buying an additional 4,338 shares in the last quarter. Kovitz Investment Group Partners LLC raised its position in shares of Medtronic by 43.8% in the first quarter. Kovitz Investment Group Partners LLC now owns 108,030 shares of the medical technology company's stock valued at $9,708,000 after buying an additional 32,907 shares during the last quarter. Finally, Inspire Trust Co. N.A. lifted its stake in Medtronic by 4.5% in the 1st quarter. Inspire Trust Co. N.A. now owns 46,000 shares of the medical technology company's stock worth $4,134,000 after purchasing an additional 2,000 shares in the last quarter. 82.06% of the stock is currently owned by institutional investors and hedge funds.</p>
<div class="lb-trans"><p>其他机构投资者最近也买卖了该公司的股票。Brighton Jones LLC 在第四季度将其在美敦力的持股比例提高了 1,368.0%。Brighton Jones LLC 现在拥有 39,989 股美敦力的股票，价值 3,194,000 美元，此前在上个季度又收购了 37,265 股。Rathbones Group PLC 在第一季度将其在美敦力的股份增加了 43.6%。Rathbones Group PLC 现在拥有 8,131 股美敦力的股票，价值 731,000 美元，此前在上个季度又购买了 2,468 股。Vestmark Advisory Solutions Inc.在第一季度将其在美敦力的持股增加了 98.4%。Vestmark Advisory Solutions Inc.现在拥有 8,746 股美敦力的股票，价值 786,000 美元，此前在上个季度又购买了 4,338 股。Kovitz Investment Group Partners LLC 在第一季度将其在美敦力的持股提高了 43.8%。Kovitz Investment Group Partners LLC 现在拥有 108,030 股美敦力的股票，价值 9,708,000 美元，此前在上个季度又购买了 32,907 股。最后，Inspire Trust Co. N.A.在第一季度将其在美敦力的股份提高了 4.5%。Inspire Trust Co. N.A.现在拥有 46,000 股美敦力的股票，价值 4,134,000 美元，此前在上个季度又购买了 2,000 股。目前，82.06% 的股票由机构投资者和对冲基金持有。</p>
</div><h2>Wall Street Analyst Weigh In</h2>
<div class="lb-trans"><h2>华尔街分析师观点</h2>
</div><p>Several research firms recently issued reports on MDT. JPMorgan Chase &amp; Co. raised their price objective on shares of Medtronic from $90.00 to $100.00 and gave the stock a &#34;neutral&#34; rating in a research report on Thursday, November 13th. Sanford C. Bernstein set a $111.00 price target on shares of Medtronic in a report on Wednesday, November 19th. Wells Fargo &amp; Company lifted their price target on shares of Medtronic from $100.00 to $114.00 and gave the company an &#34;overweight&#34; rating in a research report on Wednesday, November 19th. Robert W. Baird increased their price objective on Medtronic from $103.00 to $109.00 and gave the stock a &#34;neutral&#34; rating in a research report on Wednesday, November 19th. Finally, UBS Group lifted their target price on Medtronic from $95.00 to $102.00 and gave the company a &#34;neutral&#34; rating in a research report on Wednesday, November 19th. One analyst has rated the stock with a Strong Buy rating, thirteen have given a Buy rating and twelve have given a Hold rating to the company's stock. Based on data from MarketBeat.com, the company has an average rating of &#34;Moderate Buy&#34; and a consensus target price of $110.44.</p>
<div class="lb-trans"><p>几家研究公司最近对 MDT 发布了报告。摩根大通将美敦力的股票目标价从 90.00 美元上调至 100.00 美元，并在 11 月 13 日的研究报告中给予该股票 “中性” 评级。Sanford C. Bernstein 在 11 月 19 日的报告中设定了美敦力的目标价为 111.00 美元。富国银行在 11 月 19 日的研究报告中将美敦力的目标价从 100.00 美元上调至 114.00 美元，并给予该公司 “增持” 评级。Robert W. Baird 在 11 月 19 日的研究报告中将美敦力的目标价从 103.00 美元上调至 109.00 美元，并给予该股票 “中性” 评级。最后，瑞银集团在 11 月 19 日的研究报告中将美敦力的目标价从 95.00 美元上调至 102.00 美元，并给予该公司 “中性” 评级。一位分析师对该股票给予了强烈买入评级，十三位分析师给予买入评级，十二位分析师给予持有评级。根据 MarketBeat.com 的数据，该公司的平均评级为 “适度买入”，共识目标价为 110.44 美元。</p>
</div><ul>
<li>MarketBeat Week in Review – 08/18 - 08/22</li>
</ul>
<div class="lb-trans"><ul>
<li>MarketBeat 周回顾 – 08/18 - 08/22</li>
</ul>
</div><p><strong>View Our Latest Stock Report on MDT</strong></p>
<div class="lb-trans"><p><strong>查看我们最新的美敦力股票报告</strong></p>
</div><h2>Medtronic Trading Down 1.0%</h2>
<div class="lb-trans"><h2>美敦力股价下跌 1.0%</h2>
</div><p>Shares of NYSE MDT opened at $99.77 on Friday. The company has a current ratio of 2.42, a quick ratio of 1.80 and a debt-to-equity ratio of 0.57. The stock has a market capitalization of $127.91 billion, a PE ratio of 26.89, a PEG ratio of 2.65 and a beta of 0.71. Medtronic PLC has a twelve month low of $79.29 and a twelve month high of $106.33. The stock has a fifty day simple moving average of $97.23 and a 200-day simple moving average of $92.66.</p>
<div class="lb-trans"><p>美敦力（NYSE:MDT）股票周五开盘价为 99.77 美元。该公司的流动比率为 2.42，速动比率为 1.80，债务与股本比率为 0.57。该股票的市值为 1279.1 亿美元，市盈率为 26.89，市盈增长比率为 2.65，贝塔值为 0.71。美敦力 PLC 的 12 个月低点为 79.29 美元，12 个月高点为 106.33 美元。该股票的 50 日简单移动平均线为 97.23 美元，200 日简单移动平均线为 92.66 美元。</p>
</div><ul>
<li>Medtronic: The Opportunity Gets Healthier for Income Investors</li>
</ul>
<div class="lb-trans"><ul>
<li>美敦力：收入投资者的机会变得更好</li>
</ul>
</div><p>Medtronic (NYSE:MDT - Get Free Report) last announced its earnings results on Tuesday, November 18th. The medical technology company reported $1.36 EPS for the quarter, beating analysts' consensus estimates of $1.31 by $0.05. The company had revenue of $8.96 billion during the quarter, compared to analysts' expectations of $8.86 billion. Medtronic had a return on equity of 14.86% and a net margin of 13.71%.Medtronic's revenue for the quarter was up 6.6% on a year-over-year basis. During the same period last year, the business posted $1.26 EPS. Medtronic has set its FY 2026 guidance at 5.620-5.660 EPS. On average, equities analysts forecast that Medtronic PLC will post 5.46 earnings per share for the current year.</p>
<div class="lb-trans"><p>美敦力（NYSE:MDT - 获取免费报告）最后一次公布财报是在 11 月 18 日，医疗技术公司报告季度每股收益为 1.36 美元，超出分析师一致预期的 1.31 美元，超出 0.05 美元。该公司在本季度的收入为 89.6 亿美元，而分析师预期为 88.6 亿美元。美敦力的股本回报率为 14.86%，净利润率为 13.71%。美敦力本季度的收入同比增长 6.6%。去年同期，该公司每股收益为 1.26 美元。美敦力已将其 2026 财年的指引设定为 5.620-5.660 每股收益。分析师平均预测美敦力 PLC 在当前年度的每股收益为 5.46 美元。</p>
</div><h2>Medtronic Dividend Announcement</h2>
<div class="lb-trans"><h2>美敦力分红公告</h2>
</div><p>The firm also recently announced a quarterly dividend, which will be paid on Friday, January 16th. Investors of record on Friday, December 26th will be paid a dividend of $0.71 per share. This represents a $2.84 annualized dividend and a yield of 2.8%. The ex-dividend date of this dividend is Friday, December 26th. Medtronic's dividend payout ratio is presently 76.55%.</p>
<div class="lb-trans"><p>该公司还最近宣布了一项季度分红，将于 1 月 16 日（星期五）支付。12 月 26 日（星期五）的登记投资者将获得每股 0.71 美元的分红。这相当于每年 2.84 美元的分红，收益率为 2.8%。该分红的除息日期为 12 月 26 日（星期五）。美敦力的分红支付比率目前为 76.55%。</p>
</div><h2>About Medtronic</h2>
<div class="lb-trans"><h2>关于美敦力</h2>
</div><p>(Free Report)</p>
<div class="lb-trans"><p>（免费报告）</p>
</div><p>Medtronic plc develops, manufactures, and sells device-based medical therapies to healthcare systems, physicians, clinicians, and patients worldwide. Its Cardiovascular Portfolio segment offers implantable cardiac pacemakers, cardioverter defibrillators, and cardiac resynchronization therapy devices; cardiac ablation products; insertable cardiac monitor systems; TYRX products; and remote monitoring and patient-centered software.</p>
<div class="lb-trans"><p>美敦力公司开发、制造和销售基于设备的医疗疗法，服务于全球的医疗系统、医生、临床医生和患者。其心血管产品组合提供可植入的心脏起搏器、心脏复律除颤器和心脏再同步治疗设备；心脏消融产品；可植入心脏监测系统；TYRX 产品；以及远程监测和以患者为中心的软件。</p>
</div><h2>Featured Stories</h2>
<div class="lb-trans"><h2>精选故事</h2>
</div><ul>
<li>Five stocks we like better than Medtronic</li>
<li>Procter &amp; Gamble NYSE: PG Pulls Back After Shaky Guidance</li>
<li>Dividend Powerhouses: 3 Blue-Chip Stocks Built for the Long Haul</li>
<li>3 Home Improvement Stocks that Can Upgrade Your Portfolio</li>
<li>3 Recently Downgraded Stocks to Avoid in 2026</li>
<li>What Are the FAANG Stocks and Are They Good Investments?</li>
<li>The Chip Boom Is Back: 3 Stocks Positioned for Huge Gains</li>
</ul>
<div class="lb-trans"><ul>
<li>五只我们更看好的股票超过美敦力</li>
<li>宝洁公司（NYSE: PG）在不稳定的指引后回落</li>
<li>分红强势股：3 只为长期投资而打造的蓝筹股</li>
<li>3 只可以提升您投资组合的家居改善股票</li>
<li>3 只最近被下调评级的股票，2026 年应避免</li>
<li>FAANG 股票是什么？它们是好的投资吗？</li>
<li>芯片热潮回归：3 只有望获得巨大收益的股票</li>
</ul>
</div><p><strong>Want to see what other hedge funds are holding MDT?</strong> Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Medtronic PLC (NYSE:MDT - Free Report).</p>
<div class="lb-trans"><p><strong>想知道其他对冲基金持有 MDT 的情况吗？</strong> 请访问 HoldingsChannel.com 获取 Medtronic PLC (NYSE:MDT - 免费报告) 的最新 13F 文件和内部交易信息。</p>
</div><p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/SECFilingChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPU1EVA" alt="" original-src="https://www.marketbeat.com/scripts/SECFilingChart.ashx?Prefix=NYSE&amp;Symbol=MDT"/></p>
<p><em>This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.</em></p>
<div class="lb-trans"><p><em>此即时新闻提醒由叙事科学技术和 MarketBeat 的金融数据生成，旨在为读者提供最快的报道和公正的覆盖。请将任何问题或意见发送至 contact@marketbeat.com。</em></p>
</div><h2>Should You Invest $1,000 in Medtronic Right Now?</h2>
<div class="lb-trans"><h2>你现在应该投资 1,000 美元在 Medtronic 吗？</h2>
</div><p>Before you consider Medtronic, you'll want to hear this.</p>
<div class="lb-trans"><p>在考虑 Medtronic 之前，你需要听听这个。</p>
</div><p>MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Medtronic wasn't on the list.</p>
<div class="lb-trans"><p>MarketBeat 每天跟踪华尔街顶级评级和表现最佳的研究分析师及其推荐给客户的股票。MarketBeat 已识别出五只顶级分析师悄悄建议客户现在购买的股票，以便在更广泛的市场注意到之前……而 Medtronic 并不在名单上。</p>
</div><p>While Medtronic currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.</p>
<div class="lb-trans"><p>虽然 Medtronic 目前在分析师中有中等买入评级，但顶级分析师认为这五只股票更值得购买。</p>
</div><p>View The Five Stocks Here</p>
<div class="lb-trans"><p>在这里查看这五只股票</p>
</div>

Quantinno Capital Management LP 收购了美敦力公司 $MDT 的股票